TDAC Overview

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.

Wall Street analysts forecast TDAC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TDAC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Translational Development Acquisition Corp revenue for the last quarter amounts to 0.00 USD, decreased

Translational Development Acquisition Corp. EPS for the last quarter amounts to 0.06 USD, decreased -14.29

Translational Development Acquisition Corp (TDAC) has 10 emplpoyees as of May 27 2026.

Today TDAC has the market capitalization of 233.10M USD.